My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
FOUNTAIN VALLY, CITY OF 2
Clerk
>
Contracts / Agreements
>
INACTIVE CONTRACTS (Originals Destroyed)
>
E-F (INACTIVE)
>
FOUNTAIN VALLY, CITY OF 2
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/3/2015 4:43:07 PM
Creation date
6/6/2006 9:45:04 AM
Metadata
Fields
Template:
Contracts
Company Name
CIty of Fountain Valley
Contract #
A-2005-310-16
Agency
Police
Council Approval Date
9/19/2005
Destruction Year
2012
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
305
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Attachment C <br />Section 9 Medical Supplies and Limited Types of Pharmaceuticals <br />AEL Ref No Title /Description Fall 2004 <br />SMSP/ LETPP MMRS EMPG .SEL Ref Number <br />UASr <br />9.2.40 <br />Kit, Debridement, and Supplies 09MS-01-KDEB <br />[J ❑ <br />❑ <br />❑ <br />Single -use, disposable kit to clean soft tissue injuries and surfaces. <br />9.2.41 <br />Kit, Obstetrical 09MS-01-KTOB <br />W ❑ <br />❑ <br />❑ <br />Self-contained kit with supplies required to support obstetrical procedures. <br />9.2.42 <br />responsible for replenishing items after shelf -life expiration dates. <br />Kit, Thoracostomy and Supplies 09MS-01-THOR <br />J❑ ❑ <br />❑ <br />❑ <br />Self contained kit to perform and support chest decompression. <br />(9.3) Pharmaceuticals <br />9.3.0 <br />Pharmaceuticals <br />[] ❑ <br />❑ <br />❑ <br />Various pharmaceuticals required for response to a CBRNE terrorism <br />incident at the advanced life support level. Note that grantees are <br />responsible for replenishing items after shelf -life expiration dates. <br />9.3.1 <br />Adamantines <br />09PH-00-ADAM <br />d❑ ❑ <br />❑ <br />❑ <br />Anti-viral; FDA approved to treat and prevent INFLUENZA A viruses. <br />Includes amantadine and rimantadine. Described in Federal Pandemic <br />Influenza Preparedness and Response Plan: <br />http://www.hhs.govinvp,o/pandemicplan <br />Sample fact sheets available at: <br />hftp:/A» .niaid.nih.gov/factsheets/fludmgs.htm <br />hitp://hopkins-heic.org/infectious_diseases/influenza/facts. htm <br />9.3.2 <br />Adenosine <br />09PH-00-ADEN <br />© ❑ <br />❑ <br />[_1 <br />Anti -dysrhythmic <br />9.3.3 <br />Albuterol <br />09PH-00-ALBU <br />V] ❑ <br />❑ <br />❑ <br />Bronchodilator <br />9.3.4 <br />Amiodarone <br />09PH-00-AMIO <br />W ❑ <br />❑ <br />❑ <br />Anti -dysrhythmic <br />9.3.5 <br />Amyl Nitrite <br />09PH-00-AMNI <br />© ❑ <br />❑ <br />❑ <br />Vasodilator <br />9.3.6 <br />Antacids <br />09PH-00-ANTA <br />❑ <br />❑ <br />❑ <br />Antacid <br />9.3.7 <br />Acetylsalicylic Acid <br />09PH-00-ASA <br />0 [I <br />❑ <br />❑ <br />Anticoagulant; analgesic, anti-inflammatory; fever reduction. <br />9.3.8 <br />Atropine Sulfate <br />09PH-00-ATSF <br />V] ❑ <br />❑ <br />❑ <br />Antidote for organophosphate and nerve agent exposure. <br />Interactive versions of this appendix and the F4112004 SEL are available on-line at rvww.rkb.nupt.org. <br />Wednesday, April 27, 2005 Full AEL: Page 49 of 78 <br />
The URL can be used to link to this page
Your browser does not support the video tag.